Cover Image
市場調查報告書

Axikin Pharmaceuticals, Inc.:產品平台分析

Axikin Pharmaceuticals, Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 321970
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Axikin Pharmaceuticals, Inc.:產品平台分析 Axikin Pharmaceuticals, Inc. - Product Pipeline Review - 2014
出版日期: 2014年12月24日 內容資訊: 英文 21 Pages
簡介

Axikin Pharmaceuticals, Inc.是致力於從事治療氣喘及慢性閉塞性肺疾、發炎性皮膚疾病、類風濕性關節炎等呼吸系統,發炎性及自體免疫疾病用的小分子藥開發並商品化的生物製藥公司。

本報告提供Axikin Pharmaceuticals, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,同時也提供最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Axikin Pharmaceuticals, Inc.的基本資料

Axikin Pharmaceuticals, Inc.概要

  • 主要資訊
  • 企業資料

Axikin Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Axikin Pharmaceuticals, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Axikin Pharmaceuticals, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Axikin Pharmaceuticals, Inc.:藥物簡介

  • AXP-1275
  • Small Molecule to Antagonize G Protein Coupled Receptors for Respiratory Disorders
  • Small Molecule to Inhibit Protein Kinase for COPD

Axikin Pharmaceuticals, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Axikin Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC06715CDB

Summary

Global Markets Direct's, 'Axikin Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Axikin Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Axikin Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Axikin Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Axikin Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Axikin Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Axikin Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Axikin Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Axikin Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Axikin Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Axikin Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Axikin Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Axikin Pharmaceuticals, Inc. Snapshot
    • Axikin Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Axikin Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Axikin Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Axikin Pharmaceuticals, Inc. - Pipeline Products Glance
    • Axikin Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Axikin Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Axikin Pharmaceuticals, Inc. - Drug Profiles
    • AXP-1275
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Antagonize G Protein Coupled Receptors for Respiratory Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Protein Kinase for COPD
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Axikin Pharmaceuticals, Inc. - Pipeline Analysis
  • Axikin Pharmaceuticals, Inc. - Pipeline Products by Target
  • Axikin Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
  • Axikin Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
  • Axikin Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Axikin Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Axikin Pharmaceuticals, Inc., Key Information
  • Axikin Pharmaceuticals, Inc., Key Facts
  • Axikin Pharmaceuticals, Inc. - Pipeline by Indication, 2014
  • Axikin Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014
  • Axikin Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014
  • Axikin Pharmaceuticals, Inc. - Phase II, 2014
  • Axikin Pharmaceuticals, Inc. - Preclinical, 2014
  • Axikin Pharmaceuticals, Inc. - Discovery, 2014
  • Axikin Pharmaceuticals, Inc. - Pipeline by Target, 2014
  • Axikin Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014
  • Axikin Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014
  • Axikin Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014

List of Figures

  • Axikin Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2014
  • Axikin Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014
  • Axikin Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014
  • Axikin Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2014
  • Axikin Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2014
  • Axikin Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top